NCT00182169View on ClinicalTrials.gov

Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 1997

Study Completion Date

June 30, 2005

Conditions
Heart Failure
Interventions
DRUG

Human recombinant growth hormone

Trial Locations (1)

L8N3Z5

McMaster University, Hamilton

All Listed Sponsors
lead

Hamilton Health Sciences Corporation

OTHER

NCT00182169 - Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure | Biotech Hunter | Biotech Hunter